Respiratory Medicines Approved in the EU (EMA)

Each number has its full source under its own list below.

Medicines authorised in the EU

136 medicines (authorised now). Newest first. Each links to its EMA page.

29May2026
Imdylltra
Active substance: tarlatamab
EMEA/H/C/006451
29May2026
Zepzelca
Active substance: lurbinectedin
EMEA/H/C/006673
15Apr2026
Enflonsia
Active substance: clesrovimab
EMEA/H/C/006497
12Feb2026
Exdensur
Active substance: depemokimab
EMEA/H/C/006446
18Nov2025
Brinsupri
Active substance: Brensocatib monohydrate
EMEA/H/C/005820
22Aug2025
Nintedanib Viatris
Active substance: nintedanib
EMEA/H/C/006486
30Jun2025
Alyftrek
Active substance: deutivacaftor;tezacaftor;vanzacaftor calcium dihydrate
EMEA/H/C/006382
3Feb2025
Hetronifly
Active substance: serplulimab
EMEA/H/C/006170
20Jan2025
Lazcluze
Active substance: lazertinib mesilate monohydrate
EMEA/H/C/006074
13Jan2025
Gohibic
Active substance: vilobelimab
EMEA/H/C/006123
13Jan2025
Augtyro
Active substance: repotrectinib
EMEA/H/C/006005
22Aug2024
mResvia
Active substance: Single-stranded 5' capped mRNA encoding the respiratory syncytial virus glycoprotein F stabilised in the prefusion conformation
EMEA/H/C/006278
26Jul2024
Avzivi
Active substance: bevacizumab
EMEA/H/C/005574
24Jul2024
Cejemly
Active substance: sugemalimab
EMEA/H/C/006088
24Jul2024
Apexelsin
Active substance: paclitaxel
EMEA/H/C/005997